Osaic Holdings’s Putnam BioRevolution ETF SYNB Stock Holding History

Osaic Holdings’s Portfolio SYNB Stock Details SYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$60	–	8165
2025 Q3	$60	Hold	2	–	–	﹤0.01%	7778
2025 Q2	$56	Hold	2	–	–	﹤0.01%	7607
2025 Q1	$55	Hold	2	–	–	﹤0.01%	7277
2024 Q4	$59	Hold	2	–	–	﹤0.01%	7278
2024 Q3	$66	Buy	+2	New	+$64	﹤0.01%	7278
2023 Q1	–	Sell	-40	Closed	-$1K	–	7569
2022 Q4	$1K	Buy	+40	New	+$1.04K	﹤0.01%	6958

Osaic Holdings's SYNB Position: Q4 2025 in Review

Osaic Holdings sold out of Putnam BioRevolution ETF (SYNB) in Q4 2025, closing a stake of 2 shares — an estimated $60 sold.

Osaic Holdings first reported a position in SYNB in Q4 2022 and held it in 6 quarters. The position peaked at $1K in Q4 2022. 0 funds tracked by Wall St. Rank hold SYNB as of Q4 2025.

Osaic Holdings reported no remaining Putnam BioRevolution ETF position as of Q4 2025 after selling out during the quarter.
Osaic Holdings sold 2 Putnam BioRevolution ETF shares in Q4 2025, an estimated $60.
Osaic Holdings first reported a position in Putnam BioRevolution ETF in Q4 2022 and held it in 6 quarters.
Osaic Holdings's Putnam BioRevolution ETF position peaked at $1K in Q4 2022.
0 funds tracked by Wall St. Rank held Putnam BioRevolution ETF as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.